{
    "nctId": "NCT01817374",
    "briefTitle": "Breast VCEUS to Evaluate Early Response to Neoadjuvant Chemotherapy",
    "officialTitle": "A Pilot Study Evaluating Quantitative Volume Contrast Enhanced Ultrasound (VCEUS) Imaging for Determining Early Breast Cancer Response to Neoadjuvant Chemotherapy",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 6,
    "primaryOutcomeMeasure": "Tumor Volume Measure Using Grayscale US",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Adult patients (age 19 years or older).\n2. Patients with newly diagnosed and untreated stage II and III breast cancer scheduled to undergo neoadjuvant chemotherapy.\n3. Patients with signed informed consent.\n\nExclusion Criteria:\n\n1. Any history of prior radiation or chemotherapy for breast cancer.\n2. Patients who only have non-measurable disease.\n3. Patients who are medically unstable.\n4. Patients with other primary cancers requiring systemic treatment.\n5. Patients with cardiac shunts.\n6. Patients with unstable cardiopulmonary conditions.\n7. Patients with known pulmonary hypertension.\n8. Patients with known hypersensitivity to any component of Definity (R) microbubble contrast.\n9. Patients who are pregnant, breast-feeding or are planning to become pregnant during the study duration.",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}